Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Syncona Shs GBP ( (GB:SYNC) ) just unveiled an announcement.
Syncona Limited has announced the purchase of 150,000 of its ordinary shares as part of its ongoing share buyback program, initially announced in September 2023. The purchased shares will be held in treasury, which impacts the company’s total voting rights, now totaling 620,395,995. This strategic move is in line with Syncona’s commitment to enhance shareholder value while maintaining a robust balance sheet to support its life sciences investment initiatives.
More about Syncona Shs GBP
Syncona Limited is a leading life science investor focused on creating, building, and scaling a portfolio of globally leading life science companies. The company aims to deliver transformational treatments to patients in areas of high unmet need by partnering with world-class academic founders and experienced management teams. Syncona maintains a diversified portfolio of 20-25 life science businesses, concentrating on development stage, modality, and therapeutic area, with a long-term view to improve patient lives and deliver strong returns to shareholders.
YTD Price Performance: -10.13%
Average Trading Volume: 738,889
Technical Sentiment Consensus Rating: Buy
For detailed information about SYNC stock, go to TipRanks’ Stock Analysis page.
